Serious Adverse Event Reporting: The New MoCRA Requirement for Beauty Brands
Understanding "Cosmetovigilance": Your 15-Day Mandatory Reporting Window and Record-Keeping Obligations.
Key takeaways
- In 2026, "Cosmetovigilance" is no longer optional. The Responsible Person (the entity on the product label) must report any Serious Adverse Event (SAE) to the FDA within 15 business days of becoming aware of it. Failure to report or maintain records for 6 years (3 years for small businesses) can trigger mandatory recalls or suspension of your facility's registration.
What Qualifies as a "Serious" Adverse Event?
Under MoCRA (Section 605 of the FD&C Act), an adverse event is "serious" if it results in any of the following outcomes associated with the use of a cosmetic product:
- Death or life-threatening experiences.
- Inpatient hospitalization.
- Persistent or significant disability or incapacity.
- Congenital anomaly or birth defect.
- Infection or significant disfigurement (including serious rashes, second- or third-degree burns, or significant hair loss).
Even if a consumer uses a product incorrectly, if a serious reaction occurs, it must be reported.
The 15-Business-Day Clock
The "Responsible Person" must submit a report to the FDA via the MedWatch Form 3500A within 15 business days of receiving the initial report. This short window requires brands to have a pre-established "Intake and Triage" system to identify serious complaints the moment they arrive via customer service, email, or social media.
Ongoing Obligations and Medical Updates
Your responsibility doesn't end with the first report. If you receive "new and material" medical information related to the event within one year of the initial submission, you must provide that update to the FDA within 15 business days of receipt.
Mandatory Record-Keeping
MoCRA requires brands to maintain a complete log of all adverse events (both serious and non-serious) for a specific period:
- Standard Businesses: 6 years of records.
- Small Businesses: 3 years of records (subject to specific revenue/size criteria).
The FDA has the legal authority to request access to these logs during a facility inspection. Incomplete records are a primary cause for FDA Warning Letters in 2026.
Is Your Brand Prepared for an Audit?
A single unreported event can jeopardize your entire U.S. distribution. FDA Express helps cosmetic brands stay audit-ready with:
- Adverse Event Triage Systems: We help you set up internal SOPs to catch and classify reports instantly.
- MedWatch Submission Support: Our experts handle the technical filing of Form 3500A to ensure accuracy.
- Label Compliance: We verify that your labels include the mandatory U.S. contact information for consumer reporting.